Synthetic lethality strategies: Beyond BRCA1/2 mutations in pancreatic cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Synthetic lethality strategies: Beyond BRCA1/2 mutations in pancreatic cancer

Published:2020-08-06 Issue:9 Volume:111 Page:3111-3121
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Hu Yunlong¹,Guo Mingzhou¹²³^ORCID

Affiliation:

1. Department of Gastroenterology and Hepatology Chinese PLA General Hospital Beijing China

2. Henan Key Laboratory for Esophageal Cancer Research Zhengzhou University Zhengzhou China

3. State Key Laboratory of Kidney Diseases Chinese PLA General Hospital Beijing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14565

Reference113 articles.

1. A method for detecting abasic sites in living cells: Age-dependent changes in base excision repair

2. The DNA damage-induced cell death response: a roadmap to kill cancer cells

3. DNA Damage, Aging, and Cancer

4. The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer

5. Cancer Genome Landscapes

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methylation of FAM110C is a synthetic lethal marker for ATR/CHK1 inhibitors in pancreatic cancer;J TRANSL INTERN MED;2024

2. Two recurrent pathogenic/likely pathogenic variants in PALB2 account for almost half of PALB2 positive families in Slovenia;2024-07-08

3. Epigenetic silencing of KCTD8 promotes hepatocellular carcinoma growth by activating PI3K/AKT signaling;Epigenomics;2024-07-02

4. Potential Benefits of Combining Proton or Carbon Ion Therapy with DNA Damage Repair Inhibitors;Cells;2024-06-19

5. Functions and inhibitors of CHK1 in cancer therapy;Medicine in Drug Discovery;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3